↓ Skip to main content

Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficileinfection in mice following vancomycin treatment

Overview of attention for article published in BMC Infectious Diseases, December 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficileinfection in mice following vancomycin treatment
Published in
BMC Infectious Diseases, December 2012
DOI 10.1186/1471-2334-12-342
Pubmed ID
Authors

Yuesheng Li, Robert A Figler, Glynis Kolling, Tara C Bracken, Jayson Rieger, Ralph W Stevenson, Joel Linden, Richard L Guerrant, Cirle Alcantara Warren

Abstract

Activation of the A2A adenosine receptor (A2AAR) decreases production of inflammatory cytokines, prevents C. difficile toxin A-induced enteritis and, in combination with antibiotics, increases survival from sepsis in mice. We investigated whether A2AAR activation improves and A2AAR deletion worsens outcomes in a murine model of C. difficile (strain VPI10463) infection (CDI).

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 3%
Belgium 1 3%
Unknown 38 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 18%
Professor 5 13%
Student > Doctoral Student 4 10%
Student > Ph. D. Student 4 10%
Professor > Associate Professor 4 10%
Other 10 25%
Unknown 6 15%
Readers by discipline Count As %
Medicine and Dentistry 12 30%
Agricultural and Biological Sciences 7 18%
Immunology and Microbiology 7 18%
Neuroscience 2 5%
Biochemistry, Genetics and Molecular Biology 1 3%
Other 3 8%
Unknown 8 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 July 2016.
All research outputs
#7,177,789
of 22,689,790 outputs
Outputs from BMC Infectious Diseases
#2,365
of 7,643 outputs
Outputs of similar age
#78,860
of 278,728 outputs
Outputs of similar age from BMC Infectious Diseases
#40
of 155 outputs
Altmetric has tracked 22,689,790 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 7,643 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 278,728 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 155 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.